| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/27/2008 | US20080076124 Polypeptide comprising serine/threonine phosphatase activity for use as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 03/27/2008 | US20080075741 Recombinant P. falciparum merozoite protein-1 42 vaccine |
| 03/27/2008 | US20080075733 receptor for advanced glycosylation end products polypeptide directly linked to a polypeptide comprising a CH2 domain of an immunoglobulin; biodrug for treating amyloidosis, Alzheimer's disease, cancer, autoimmune disease, inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075726 Anti-IL-6 monoclonal antibodies and uses thereof |
| 03/27/2008 | US20080075724 Nucleotide sequeces coding protein for use in the detection, diagnosis and treatment cell proliferative, autoimmune diseases, inflammation and infection; biodrugs as antiinflammatory agents, antiproliferative agents |
| 03/27/2008 | US20080075720 fusion proteins comprising antibody variable domains that binds to factor B and a targeting moiety comprising a complement receptor or fragment, used to reduce or prevent airway hyperresponsiveness and inflammation, for treating ischemia-reperfusion injuries, rhinitis and respiratory system disorders |
| 03/27/2008 | US20080075672 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 03/27/2008 | US20080075659 Determining the percentage of monoclonal, chimerized, murine or humanized antibody greater than 90 percent using excess amount of CD66 antigen, and the percentage of immunoreactive antibody that binds specifically to CD66 |
| 03/27/2008 | CA2664178A1 Vipr1s as modifiers of the e2f/rb pathway and methods of use |
| 03/27/2008 | CA2663052A1 Genetically programmed expression of selectively sulfated proteins in eubacteria |
| 03/26/2008 | EP1903115A1 Process for the fermentative production of antibodies |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
| 03/26/2008 | EP1903111A2 Extended cDNAs for secreted proteins |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903055A2 Recombinant haemophilus influenzae adhesin proteins |
| 03/26/2008 | EP1903033A1 Coniosetine, process for preparation and use as pharmaceutical |
| 03/26/2008 | EP1458866B1 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
| 03/26/2008 | EP0714405B1 Therapeutic and diagnostic agents for amyloidosis |
| 03/26/2008 | EP0672147B1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 03/26/2008 | CN101151369A Dipeptide crystals and process for production thereof |
| 03/26/2008 | CN101151366A In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| 03/26/2008 | CN101151300A Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions |
| 03/26/2008 | CN101151276A Method of producing protein by using hamster IGF-1 |
| 03/26/2008 | CN101151272A Recombinant icosahedral virus like particle production in pseudomonads |
| 03/26/2008 | CN101148662A Heterogenous expression and purifying method for human AIDS virus auxiliary receptor CCR5 |
| 03/26/2008 | CN101148637A Hydrolysate enriched with biological bioactive peptide for accelerating beer yeast fermenting and its preparation method and application |
| 03/26/2008 | CN101148476A Inflammation related disease target treatment fusion protein |
| 03/26/2008 | CN101147530A Preparation technology of feed additive biologically active small peptide |
| 03/26/2008 | CN100376684C Process for preparing bacteriostatic peptide by discarded tobacco leaf protein |
| 03/26/2008 | CN100376597C Polypeptide for decreasing blood pressure, its separation method and uses |
| 03/25/2008 | US7348423 Nucleic acids encoding fusion peptides |
| 03/25/2008 | US7348420 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348418 Comprises nucleotide sequences coding oncogenic polypeptides for diagnosis, detection and treatment of cancer |
| 03/25/2008 | US7348414 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 03/25/2008 | US7348413 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferfative disorders; immunotherapy; immunodiagnostics |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348407 Stress-responsive activator of p300 (strap) protein |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348172 DNA constructs for obtaining in a filamentous fungus host (actinomycete) a higher production level of a carbohydrate degrading (CD) enzyme, having in its original state a catalytic module (CAT) and a carbohydrate binding module (CBM) separated by a linker region; Xylanase; use in paper industry |
| 03/25/2008 | US7348170 proteins comprising amino acid sequences and having oxidoreductase activity, coded by DNA sequences exogenously introduced into filamentous fungi; genetic vectors |
| 03/25/2008 | US7348168 Polypeptides having cellobiohydrolase II activity and polynucleotides encoding same |
| 03/25/2008 | US7348163 screening compounds for modulation of gamma -aminobutyric acid (GABA-B subtype) receptor transcription; comprises firefly luciferase as reporter gene |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348155 Method for identifying compounds for treating aging processes in the coronary circulatory system |
| 03/25/2008 | US7348154 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on wild-type IGFBP-3 and IGF agonist peptides; KIRA phosphorylation |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348134 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening |
| 03/25/2008 | US7348007 Mage C2 antigenic peptides and uses thereof |
| 03/25/2008 | US7348004 Immunoglobulin chimeric monomer-dimer hybrids |
| 03/25/2008 | US7348003 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |
| 03/25/2008 | US7348001 Protein that includes a heavy chain immunoglobulin variable domain sequence and a light chain immunoglobulin variable domain sequence; the protein ligand binds to Tie1 ectodomain, a receptor tyrosine kinase protein that includes a transmembrane domain; use in modulating angiogenesis |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2189984C P75 tnf receptor promoters |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/25/2008 | CA2084079C Glycogen biosynthetic enzymes in plants |
| 03/25/2008 | CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression |
| 03/25/2008 | CA1341569C Microbial production of human fibroblast interferon |
| 03/20/2008 | WO2008033374A2 Ocl-2a3 compositions and uses thereof |
| 03/20/2008 | WO2008032833A1 Antibody having enhanced adcc activity and method for production thereof |
| 03/20/2008 | WO2008032783A1 Artificial antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032712A1 Monoclonal antibody and use thereof |
| 03/20/2008 | WO2008032659A1 Secretion signal peptide having improved efficiency, and method for production of protein by using the same |
| 03/20/2008 | WO2008031196A1 Treatment of aged skin with autologous growth factors in a hyaluronic acid delivery system |
| 03/20/2008 | WO2007130453A3 Non-natural amino acid substituted polypeptides |
| 03/20/2008 | US20080072352 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same |
| 03/20/2008 | US20080072351 Fatty Acid Desaturases and Uses Thereof |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070840 Polypeptides or peptides modified to include at least one antibody Fc region and, optionally, one or more water soluble polymers; have ability to stimulate in vivo and in vitro production of platelets, and/or megakaryocytopoietic activity, i.e., the ability to stimulate production of platelet precursors |
| 03/20/2008 | US20080070835 Hla-Dr-Binding Antigen Peptide Derived From Wt1 |
| 03/20/2008 | US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 03/20/2008 | US20080070829 Family of pesticidal proteins and methods for their use |
| 03/20/2008 | US20080070828 Ace-Inhibitory Whey Hydrolysates |
| 03/20/2008 | US20080070280 Product quality enhancement in mammalian cell culture processes for protein production |
| 03/20/2008 | US20080070279 Group of Synthetic Antimicrobal Peptides |
| 03/20/2008 | US20080070278 Immunoglobulin fusion comprising clostridial light chain for use in controlling interaction of particular cell types with their external environment; drug targeting and delivery |
| 03/20/2008 | US20080070277 Homologous Amds Genes as Selectable Marker |
| 03/20/2008 | US20080070276 Transcriptional Termination of Transgene Expression Using Host Genomic Terminators |
| 03/20/2008 | US20080070275 Factor VIII: Remodeling and glycoconjugation of factor VIII |
| 03/20/2008 | US20080070251 Method of Producing Factor VIII Proteins by Recombinant Methods |
| 03/20/2008 | US20080070246 Recombinant protein and method of screening for agents that modulate polypeptide aggregation |
| 03/20/2008 | US20080070232 Expression Vectors Containing a Truncated Epstein Barr Nuclear Antigen 1 Lacking the Gly-Gly-Ala Domain for Enhanced Transient Gene Expression |
| 03/20/2008 | US20080069922 Oil Seed Processing |
| 03/20/2008 | US20080069829 Ability to bind to antibodies; diagnosis of allergies |
| 03/20/2008 | US20080069821 Avian pandemic; immunogens; antibodies; immunology |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069800 System for High Production of Natural and Personalized Interferons |
| 03/20/2008 | US20080069775 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | CA2842966A1 Cell culture improvements |
| 03/20/2008 | CA2842964A1 Cell culture improvements |
| 03/20/2008 | CA2842959A1 Cell culture improvements |
| 03/20/2008 | CA2663442A1 Cell culture improvements |
| 03/20/2008 | CA2662962A1 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 03/19/2008 | EP1900816A2 GL50 molecules and uses therefor |
| 03/19/2008 | EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto |